Hematologic Malignancies: New Therapies and the Evolving Role of Transplant 2017

Chicago , IL US
March 17, 2017 to March 18, 2017

Course Directors: William J. Hogan, M.B., B.Ch. and Mark R. Litzow, M.D.

This two-day program focuses on the role of new therapies in treating patients with hematologic malignancies and place the evolving role of blood and marrow transplantation (BMT) in the appropriate context of these new therapies. An overview of the role of BMT in many of the hematologic malignancies is discussed, as well as an update on new cellular therapies related to BMT and how to best provide long-term follow-up for these patients.

Course Materials
A comprehensive course syllabus is provided to attendees on the course website approximately one week before the course.  No printed syllabus is available.

Registration Fees

Full Fee: M.D., DO, Ph.D.$450.00
Reduced Rate: RN, NP, PA, Student, Retiree$350.00

Additional Information
Exhibitor Invitation (PDF)
Lodging Accommodations
Credit Information
Program Schedule (PDF)
Brochure (PDF)

Course summary
Available credit: 
  • 11.00 AMA PRA Category 1 Credit
Event starts: 
03/17/2017 - 7:00am
Event ends: 
03/18/2017 - 5:00pm
The Westin Chicago River North
320 North Dearborn Street
Chicago , IL 60654
United States

Available Credit

  • 11.00 AMA PRA Category 1 Credit

Accreditation Period

Course opens: 
Course expires: 


Please login or create an account to take this course.